These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 25366059)
1. A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy. Futamura G; Kawabata S; Siba H; Kuroiwa T; Suzuki M; Kondo N; Ono K; Sakurai Y; Tanaka M; Todo T; Miyatake S Radiat Oncol; 2014 Nov; 9():237. PubMed ID: 25366059 [TBL] [Abstract][Full Text] [Related]
2. Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience. Bortolussi S; Postuma I; Protti N; Provenzano L; Ferrari C; Cansolino L; Dionigi P; Galasso O; Gasparini G; Altieri S; Miyatake SI; González SJ Radiat Oncol; 2017 Aug; 12(1):130. PubMed ID: 28806981 [TBL] [Abstract][Full Text] [Related]
3. [Secondary malignomas following radiotherapy of breast carcinoma: a case report]. Waller M; Schwarz R; Hess A Strahlenther Onkol; 1990 Feb; 166(2):140-2. PubMed ID: 2107585 [TBL] [Abstract][Full Text] [Related]
4. Radiation-induced osteosarcomas after treatment for frontal gliomas: a report of two cases. Ito T; Ozaki Y; Sato K; Oikawa M; Tanino M; Nakamura H; Tanaka S Brain Tumor Pathol; 2010 Oct; 27(2):103-9. PubMed ID: 21046312 [TBL] [Abstract][Full Text] [Related]
5. Potential of using boric acid as a boron drug for boron neutron capture therapy for osteosarcoma. Hsu CF; Lin SY; Peir JJ; Liao JW; Lin YC; Chou FI Appl Radiat Isot; 2011 Dec; 69(12):1782-5. PubMed ID: 21420871 [TBL] [Abstract][Full Text] [Related]
6. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy. Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838 [TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas. Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173 [TBL] [Abstract][Full Text] [Related]
8. Radiation-induced meningiomas after BNCT in patients with malignant glioma. Kageji T; Sogabe S; Mizobichi Y; Nakajima K; Shinji N; Nakagawa Y Appl Radiat Isot; 2015 Dec; 106():256-9. PubMed ID: 26122975 [TBL] [Abstract][Full Text] [Related]
9. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011). Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787 [TBL] [Abstract][Full Text] [Related]
10. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT). Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727 [TBL] [Abstract][Full Text] [Related]
11. Radiation injury of boron neutron capture therapy using mixed epithermal- and thermal neutron beams in patients with malignant glioma. Kageji T; Nagahiro S; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H Appl Radiat Isot; 2004 Nov; 61(5):1063-7. PubMed ID: 15308193 [TBL] [Abstract][Full Text] [Related]
12. Radiation-induced osteosarcoma of the sphenoid bone. Tanaka S; Nishio S; Morioka T; Fukui M; Kitamura K; Hikita K Neurosurgery; 1989 Oct; 25(4):640-3. PubMed ID: 2797401 [TBL] [Abstract][Full Text] [Related]
13. Comparison of BNCT and GdNCT efficacy in treatment of canine cancer. Mitin VN; Kulakov VN; Khokhlov VF; Sheino IN; Arnopolskaya AM; Kozlovskaya NG; Zaitsev KN; Portnov AA Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S299-301. PubMed ID: 19428264 [TBL] [Abstract][Full Text] [Related]
14. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT; Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940 [TBL] [Abstract][Full Text] [Related]
15. Radiation-induced osteosarcoma 16 years after surgery and radiation for glioma--case report. Watanabe T; Fuse T; Umezu M; Yamamoto M; Demura K; Niwa Y Neurol Med Chir (Tokyo); 2006 Jan; 46(1):51-4. PubMed ID: 16434828 [TBL] [Abstract][Full Text] [Related]
17. Radiation-induced osteosarcoma of the skull mimicking cutaneous tumor after treatment for frontal glioma. Maruyama A; Yasuoka S; Katoh N; Asai J J Dermatol; 2020 Jan; 47(1):69-71. PubMed ID: 31637750 [TBL] [Abstract][Full Text] [Related]
18. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT. Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923 [TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy for glioblastoma. Yamamoto T; Nakai K; Matsumura A Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207 [TBL] [Abstract][Full Text] [Related]
20. Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report. Haginomori S; Miyatake S; Inui T; Araki M; Kawabata S; Takamaki A; Lee K; Takenaka H; Kuroiwa T; Uesugi Y; Kumada H; Ono K Head Neck; 2009 Mar; 31(3):412-8. PubMed ID: 18767175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]